相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Organic acid blends improve intestinal integrity, modulate short-chain fatty acids profiles and alter microbiota of broilers under necrotic enteritis challenge
Alip Kumar et al.
ANIMAL NUTRITION (2022)
Short-chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo
Yanan Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
Fengqin Shi et al.
SCIENTIFIC REPORTS (2021)
Using probiotics for type 2 diabetes mellitus intervention: Advances, questions, and potential
Zhongke Sun et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
Gut commensal derived-valeric acid protects against radiation injuries
Yuan Li et al.
GUT MICROBES (2020)
Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice
Yanming Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Different Effects of Premature Infant Formula and Breast Milk on Intestinal Microecological Development in Premature Infants
Cheng Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
Leuconostoc mesenteroides fermentation produces butyric acid and mediates Ffar2 to regulate blood glucose and insulin in type 1 diabetic mice
Supitchaya Traisaeng et al.
SCIENTIFIC REPORTS (2020)
Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways
Richard L. Jayaraj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Short chain fatty acids in human gut and metabolic health
E. E. Blaak et al.
BENEFICIAL MICROBES (2020)
GLP-1 receptor agonists in the treatment of type 2 diabetes-state-of-the-art
Michael A. Nauck et al.
MOLECULAR METABOLISM (2020)
Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor
Rui Han et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Butyric Acid and Leucine Induce α-Defensin Secretion from Small Intestinal Paneth Cells
Akiko Takakuwa et al.
NUTRIENTS (2019)
Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway
Bryan A. Blakeney et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas et al.
FRONTIERS IN IMMUNOLOGY (2019)
Probiotics, prebiotics and amelioration of diseases
Yu-Ling Tsai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists
Yehuda Handelsman et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2018)
Short-chain fatty acids in control of energy metabolism
Jiamiao Hu et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
Vitamin D Status, Latitude and their Associations with Some Health Parameters in Children: National Food and Nutrition Surveillance
Bahareh Nikooyeh et al.
JOURNAL OF TROPICAL PEDIATRICS (2017)
Short chain fatty acids (butyric acid) and intestinal diseases
David Manrique Vergara et al.
NUTRICION HOSPITALARIA (2017)
Is GLP-1 a hormone: Whether and When?
David D'Alessio
JOURNAL OF DIABETES INVESTIGATION (2016)
Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method
Lihua Cai et al.
PLOS ONE (2015)
Correlation between the human fecal microbiota and depression
A. Naseribafrouei et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
Butyric acid: what is the future for this old substance?
Paolo Sossai
SWISS MEDICAL WEEKLY (2012)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics) - preclinical and clinical results
Sten Madsbad
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
分享论文
